LPL and fatty liver disease: Dikker et al. [42] believed that ANGPTL4 regulates plasma lipoprotein levels by inhibiting LPL activity and thus performed a cohort study to evaluate the relationship between serum ANGPTL4 levels and obesity and hepatic steatosis in adolescents.